Literature DB >> 17766602

Complications of exteriorized compared with in situ uterine repair at cesarean delivery under spinal anesthesia: a randomized controlled trial.

Mughina Siddiqui1, Eric Goldszmidt, Shafagh Fallah, John Kingdom, Rory Windrim, Jose C A Carvalho.   

Abstract

OBJECTIVE: To compare intraoperative complications of exteriorized and in situ uterine repair during elective cesarean delivery under spinal anesthesia.
METHODS: This study was a randomized, single-blinded trial in 80 women undergoing elective cesarean delivery under spinal anesthesia. Patients were randomly assigned to exteriorized or in situ uterine repair. Obstetricians were asked to perform assisted delivery of the placenta. Spinal anesthesia and oxytocin management were standardized. Phenylephrine was used to maintain systolic blood pressure within 10% of the baseline. The primary outcome was intraoperative, postdelivery nausea or vomiting.
RESULTS: Postdelivery nausea or vomiting (18% compared with 38%; P=.04) and tachycardia (3% compared with 18%; P=.03) were significantly reduced in the in situ group compared with the exteriorized group. The duration of uterine repair was significantly shorter in the exteriorized group (median 10 minutes [first and third quartiles 9, 13], compared with 11 minutes [9, 15]) (P=.04). The duration of surgery (36 minutes [30, 41] compared with 37 minutes [30, 45]) and estimated blood loss (mean+/-standard deviation 625+/-489 mL compared with 653+/-416 mL) were similar between the in situ and the exteriorized groups. There was no correlation between duration of uterine repair and estimated blood loss.
CONCLUSION: Exteriorization of the uterus for repair is associated with an increased incidence of nausea and vomiting and tachycardia during cesarean delivery under spinal anesthesia. Uterine repair should be done in situ where possible. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00452972 LEVEL OF EVIDENCE: I.

Entities:  

Mesh:

Year:  2007        PMID: 17766602     DOI: 10.1097/01.AOG.0000277712.67230.22

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

Review 1.  Extra-abdominal versus intra-abdominal repair of the uterine incision at caesarean section.

Authors:  D Jacobs-Jokhan; G Hofmeyr
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

2.  A randomized trial of phenylephrine infusion versus bolus dosing for nausea and vomiting during Cesarean delivery in obese women.

Authors:  Ronald B George; Dolores M McKeen; Jennifer E Dominguez; Terrence K Allen; Patricia A Doyle; Ashraf S Habib
Journal:  Can J Anaesth       Date:  2017-12-05       Impact factor: 5.063

3.  Effect of flurbiprofen, metoclopramide and droperidol for nausea and emesis during cesarean section under spinal anesthesia.

Authors:  Masafumi Kimura; Tomonori Okamoto; Hiroshi Tsukagoshi; Jun Sato; Shigeru Saito
Journal:  J Anesth       Date:  2011-07-26       Impact factor: 2.078

4.  Uterine exteriorization versus in situ repair in Cesarean delivery: a systematic review and meta-analysis.

Authors:  Hon Sen Tan; Cameron R Taylor; Nadir Sharawi; Rehena Sultana; Karen D Barton; Ashraf S Habib
Journal:  Can J Anaesth       Date:  2021-11-22       Impact factor: 6.713

5.  Improvement of quality of reporting in randomised controlled trials to prevent hypotension after spinal anaesthesia for caesarean section.

Authors:  A Herdan; R Roth; D Grass; M Klimek; S Will; B Schauf; R Rossaint; M Heesen
Journal:  Gynecol Surg       Date:  2010-12-18

6.  Uterine exteriorization versus intraperitoneal repair: effect on intraoperative nausea and vomiting during repeat cesarean delivery - A randomized clinical trial.

Authors:  M S Abdellah; A M Abbas; M K Ali; A Mahmoud; S A Abdullah
Journal:  Facts Views Vis Obgyn       Date:  2018-09

7.  The Health Impact of Surgical Techniques and Assistive Methods Used in Cesarean Deliveries: A Systemic Review.

Authors:  Li-Hsuan Wang; Kok-Min Seow; Li-Ru Chen; Kuo-Hu Chen
Journal:  Int J Environ Res Public Health       Date:  2020-09-21       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.